Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Cobalt Toxicity Complication of Hip Replacement Surgery

Kimberly Retzlaff  |  Issue: September 2014  |  September 1, 2014

The FDA further noted that patients who are at risk for “increased device wear and/or adverse local tissue reactions should be followed more closely.” Those identified as being at higher risk are:

  • Women;
  • Patients who are overweight or with high levels of physical activity;
  • Patients with bilateral implants, resurfacing systems with small femoral heads (44 mm or smaller), suboptimal alignment of device components or suspected metal sensitivity (e.g., cobalt, chromium, nickel);
  • Patients taking high doses of corticosteroids;
  • Patients who have evidence of renal insufficiency; and
  • Patients with suppressed immune systems.

“As a practicing rheumatologist, I would say [that for] any patient you see who has new-onset thyroid disease or unexplained heart failure and [has] either a metal-on-metal or metal-on-polyethylene joint, think about metal poisoning,” Dr. Bunning recommends. For rheumatologists, if a patient with an artificial hip has hip pain, “the usual reflex is to send [the patient] back to the orthopedic surgeon,” he says. However, rheumatologists also may opt to order a cobalt level or MRI with the appropriate sequences. If cobalt levels come back elevated or the MRI is abnormal, he says, it’s appropriate to work together with the orthopedic surgeon to manage the patient’s treatment.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Kimberly J. Retzlaff is a medical journalist based in Denver.

Acknowledgment: The author and The Rheumatologist thank Dr. Bunning for his assistance in the development of this story.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Allen LA, Ambardekar AV, Devaraj KM, et al. Clinical problem-solving. Missing elements of the history. N Engl J Med. 2014 Feb 6;370(6):559–566.
  2. Dahms K, Sharkova Y, Heitland P, et al. Cobalt intoxication diagnosed with the help of Dr. House. Lancet. 2014 Feb 8;383(9916):574.
  3. CBS Evening News with Scott Pelley. Feb. 7, 2014. https://archive.org/details/WUSA_20140207_233000_CBS_Evening_News_With_Scott_Pelley#start/1260/end/1320.
  4. Kolata G. As seen on TV, a medical mystery involving hip implants is solved. The New York Times. 2014 Feb 6;A7.
  5. Family practice. House M.D. Feb 7, 2011. http://www.imdb.com/title/tt1726372.
  6. Cobalt poisoning. MedlinePlus. http://www.nlm.nih.gov/medlineplus/ency/article/002495.htm.
  7. Morin Y, Daniel P. Quebec beer-drinkers’ cardiomyopathy: Etiological considerations. Can Med Assoc J. 1967;97(15):926–928.
  8. Mao X, Wong AA, Crawford RW. Cobalt toxicity—an emerging clinical problem in patients with metal-on-metal hip prostheses? Med J Aust. 2011;194(12):649–651.
  9. Cooper HJ, Della Valle CJ, Berger RA, et al. Corrosion at the head-neck taper as a cause for adverse local tissue reactions after total hip arthroplasty. J Bone Joint Surg Am. 2012;94(18):1655–1661.
  10. FDA safety communication: Metal-on-metal hip implants. U.S. Food and Drug Administration. Jan. 17, 2013. http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm335775.htm. Accessed May 26, 2014.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:hip replacementimagingimplantPainpatient careResearchRetzlaffrheumatologistSafetysurgerytoxicity

Related Articles
    Monkey Business Images/shutterstock.com

    Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

    December 15, 2016

    My nurse, Joanne, took me aside before I began my next consult. “Room No. 5, breast implant patient. Her lawyer organized the records.” She handed me a hefty three-ring notebook organized by color-coded tabs. “Her attorney called just now,” Joanne raised an eyebrow, “and told me to tell you that, to save time, he highlighted…

    Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement

    December 1, 2014

    Resurfacing procedure preserves bone, lasts longer, allows patients higher level of functionality

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Ocular Disease Monitoring Critical to Avoid Retinal Toxicity from Hydroxychloroquine

    November 16, 2016

    Both due to its efficacy and favorable side effect profile when compared with alternative drugs for rheumatologic conditions, hydroxychloroquine is an important agent in rheumatologists’ armamentarium. However, one barrier to hydroxychloroquine use can be its effects on the eye (also see “Revised Retinopathy Screening Guidelines,”). Ocular side effects of hydroxychloroquine can include impact on the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences